EVALUATING THE SAFETY OF CONCURRENT INTRAVENOUS HEPARIN WITH INTRAVENOUS ALTEPLASE IN PATIENTS WITH VALVE THROMBOSIS: A CASE SERIES
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)32664-0
Abstract: Currently there are no clear recommendations in ACC/AHA guidelines in regards to the role or the intensity of intravenous (IV) heparin with IV alteplase during acute thrombolysis of prosthetic valves. The most recent valvular heart… read more here.
Keywords: heparin; concurrent intravenous; intravenous heparin; alteplase ... See more keywords
Evaluating safety in hyaluronic acid lip injectionS.
Sign Up to like & getrecommendations! Published in 2021 at "Expert opinion on drug safety"
DOI: 10.1080/14740338.2021.1962283
Abstract: INTRODUCTION Soft tissue filler augmentation has become increasingly popular due to its perceived ease and impressive results. Unfortunately, although the results are impressive, so are the reported complications. This article describes complications specific to peri-oral… read more here.
Keywords: soft tissue; tissue filler; safety; hyaluronic acid ... See more keywords
Results of a phase Ib trial evaluating the safety and clinical activity of sapanisertib (TAK 228) in combination with serabelisib (TAK 117) and paclitaxel in patients with advanced ovarian, endometrial, or breast cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.3604
Abstract: 3604Background: The link between taxane resistance and activation of PI3K/AKT/mTOR signaling suggests that by inhibiting this pathway in combination with anti-microtubule agents like paclitaxel may... read more here.
Keywords: combination; results phase; paclitaxel; evaluating safety ... See more keywords